{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:53:26Z","timestamp":1769111606494,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.drudis.2023.103571","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T11:53:09Z","timestamp":1679917989000},"page":"103571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Polymeric micelles as potent islet amyloid inhibitors: Current advances and future perspectives"],"prefix":"10.1016","volume":"28","author":[{"given":"Jaskiran","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indu","family":"Pal Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Kumar Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103571_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2023.103571_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dci21-0051","article-title":"Heterogeneity of diabetes: \u03b2-cells, phenotypes, and precision medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research\u2019s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health","volume":"45","author":"Cefalu","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.drudis.2023.103571_b0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/dom.12727","article-title":"Pancreatic \u03b2-cell identity in diabetes","volume":"18","author":"Remedi","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.drudis.2023.103571_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11892-019-1194-6","article-title":"Alterations in beta cell identity in type 1 and type 2 diabetes","volume":"19","author":"Moin","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.drudis.2023.103571_b0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01219652","article-title":"The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus","volume":"15","author":"Westermark","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2023.103571_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/19382014.2019.1599707","article-title":"Islet amyloidosis in a child with type 1 diabetes","volume":"11","author":"Beery","year":"2019","journal-title":"Islets"},{"key":"10.1016\/j.drudis.2023.103571_b0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/17425247.2022.2087629","article-title":"Biomedical applications of polymeric micelles in the treatment of diabetes mellitus: current success and future approaches","volume":"19","author":"Kaur","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.drudis.2023.103571_b0040","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/D0MA00807A","article-title":"Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges","volume":"2","author":"Baig","year":"2021","journal-title":"Mater Adv"},{"key":"10.1016\/j.drudis.2023.103571_b0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2021.04.014","article-title":"Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: breakthroughs and bottlenecks","volume":"334","author":"Kaur","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2023.103571_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121987","article-title":"Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies","volume":"624","author":"Kaur","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103571_b0055","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1021\/la901776a","article-title":"Glucose-responsive micelles from self-assembly of poly(ethylene glycol)-a-poly(acrylic acid-co-acrylamidophenylboronic acid) and the controlled release of insulin","volume":"25","author":"Wang","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.drudis.2023.103571_b0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/acsmacrolett.1c00200","article-title":"Self-assembled nanochaperones inhibit the aggregation of human islet amyloid polypeptide associated with type 2 diabetes","volume":"10","author":"Niu","year":"2021","journal-title":"ACS Macro Lett"},{"key":"10.1016\/j.drudis.2023.103571_b0065","first-page":"1","article-title":"Dual effect of PEG-PE micelle over the oligomerization and fibrillation of human islet amyloid polypeptide","volume":"8","author":"Fang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103571_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","article-title":"Islet amyloid polypeptide: a partner in crime with A\u03b2 in the pathology of Alzheimer\u2019s disease","volume":"13","author":"Raimundo","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2023.103571_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9061713","article-title":"Link between diabetes and Alzheimer\u2019s disease due to the shared amyloid aggregation and deposition involving both neurodegenerative changes and neurovascular damages","volume":"9","author":"Stanciu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2023.103571_b0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","article-title":"Mechanisms of islet amyloidosis toxicity in type 2 diabetes","volume":"587","author":"Abedini","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.drudis.2023.103571_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1573399811309010025","article-title":"Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes","volume":"9","author":"Fu","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.drudis.2023.103571_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/isl.20477","article-title":"Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects","volume":"4","author":"Tomita","year":"2012","journal-title":"Islets"},{"key":"10.1016\/j.drudis.2023.103571_b0095","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/bi802097b","article-title":"Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin","volume":"48","author":"Wei","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2023.103571_b0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biocel.2005.12.009","article-title":"Role of islet amyloid in type 2 diabetes mellitus","volume":"38","author":"H\u00f6ppener","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.drudis.2023.103571_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim Biophys Acta \u2013 Mol Basis Dis"},{"key":"10.1016\/j.drudis.2023.103571_b0110","first-page":"1","article-title":"Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly","volume":"13","author":"Xu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2023.103571_b0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jmb.2011.12.035","article-title":"Amphiphilic adsorption of human islet amyloid polypeptide aggregates to lipid\/aqueous interfaces","volume":"421","author":"Xiao","year":"2012","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.drudis.2023.103571_b0120","first-page":"3","article-title":"Type 2 diabetes as a misfolding disease","volume":"155","author":"Mukherjee","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2023.103571_b0125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.drudis.2022.02.005","article-title":"Recent advances in developing polymeric micelles for treating cancer: breakthroughs and bottlenecks in their clinical translation","volume":"27","author":"Kaur","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2023.103571_b0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/polym3010252","article-title":"Functionalization of Block Copolymer Vesicle Surfaces","volume":"3","author":"Egli","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.drudis.2023.103571_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers10070238","article-title":"Micelles structure development as a strategy to improve smart cancer therapy","volume":"10","author":"Hanafy","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2023.103571_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11426-021-1155-9","article-title":"Self-assembled nanochaperones enable the disaggregation of amyloid insulin fibrils","volume":"65","author":"Wang","year":"2022","journal-title":"Sci China Chem"},{"issue":"2","key":"10.1016\/j.drudis.2023.103571_b0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/nano9020285","article-title":"Controlling the self-assembly of biomolecules into functional nanomaterials through internal interactions and external stimulations: a review","volume":"9","author":"Wang","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.drudis.2023.103571_b0150","doi-asserted-by":"crossref","first-page":"30627","DOI":"10.1039\/C7CP06670H","article-title":"Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide","volume":"19","author":"Xing","year":"2017","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.drudis.2023.103571_b0155","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1039\/D1TB02775A","article-title":"Conformational-specific self-assembled peptides as dual-mode, multi-target inhibitors and detectors for different amyloid proteins","volume":"10","author":"Ren","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.drudis.2023.103571_b0160","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1039\/C8SC05771K","article-title":"A cationic polymethacrylate-copolymer acts as an agonist for \u03b2-amyloid and an antagonist for amylin fibrillation","volume":"10","author":"Sahoo","year":"2019","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2023.103571_b0165","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1074\/jbc.M809085200","article-title":"Dynamic \u03b1-helix structure of micelle-bound human amylin","volume":"284","author":"Patil","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2023.103571_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109960","article-title":"Advances in designing of polymeric micelles for biomedical application in brain related diseases","volume":"361","author":"Kaur","year":"2022","journal-title":"Chem Biol Interact"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:03:24Z","timestamp":1761224604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644623000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1359644623000879"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103571","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric micelles as potent islet amyloid inhibitors: Current advances and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103571"}}